EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC-ND 4.0

Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]

Fei Teng, Haina Wang

Pharmaceutical Science Advances · 2026-12 · 4 · 100142

DOI: 10.1016/j.pscia.2026.100142 ↗

Kurz gefasst

Korrektur in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Fei Teng und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, PR China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[This corrects the article DOI: 10.1016/j.pscia.2025.100063.].

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Shandong University, Jinan, 250012, PR China.

Zitieren

APA

Teng, F., & Wang, H. (2026). Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]. Pharmaceutical Science Advances, 4, 100142. https://doi.org/10.1016/j.pscia.2026.100142

Vancouver

Teng F, Wang H. Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]. Pharmaceutical Science Advances. 2026;4:100142. doi:10.1016/j.pscia.2026.100142

BibTeX
@article{Teng2026,
  author = {Teng, Fei and Wang, Haina},
  title = {Corrigendum to “Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice” [Pharm. Sci. Adv. 3 (2025) 100063]},
  journal = {Pharmaceutical Science Advances},
  year = {2026},
  volume = {4},
  pages = {100142},
  doi = {10.1016/j.pscia.2026.100142}
}
Kostenlos starten →